Axel Ullrich
[[File:"_prefix)-->|" prefix)-->|thumb]] Axel Ullrich (born October 19, 1943) is a renowned German cancer researcher and biochemist. He is best known for his pioneering work in the field of molecular biology and oncology, particularly for his contributions to the development of targeted cancer therapies.
Early Life and Education[edit | edit source]
Axel Ullrich was born in Lauban, Germany. He pursued his undergraduate studies in biochemistry at the University of Tübingen and later obtained his Ph.D. in molecular genetics from the University of Heidelberg.
Career[edit | edit source]
Ullrich began his career at the Max Planck Institute of Biochemistry in Martinsried, where he conducted significant research on the human genome. He later moved to the University of California, San Francisco (UCSF), where he worked on the insulin gene and its role in diabetes.
Key Contributions[edit | edit source]
One of Ullrich's most notable achievements is the development of Herceptin (trastuzumab), a monoclonal antibody used in the treatment of HER2-positive breast cancer. This groundbreaking work has had a profound impact on the treatment of breast cancer and has paved the way for the development of other targeted therapies.
Ullrich has also made significant contributions to the understanding of signal transduction pathways in cancer cells. His research has led to the identification of several key oncogenes and tumor suppressor genes.
Awards and Honors[edit | edit source]
Axel Ullrich has received numerous awards for his contributions to science, including the Robert Koch Prize, the Wolf Prize in Medicine, and the Lasker-DeBakey Clinical Medical Research Award.
Current Work[edit | edit source]
Ullrich continues to be actively involved in cancer research. He is currently a director at the Max Planck Institute of Biochemistry and holds a professorship at the Ludwig Maximilian University of Munich.
Related Pages[edit | edit source]
- Cancer
- Biochemistry
- Molecular biology
- Oncology
- Monoclonal antibody
- Signal transduction
- Oncogene
- Tumor suppressor gene
- Herceptin
- Max Planck Institute of Biochemistry
- University of California, San Francisco
- University of Tübingen
- University of Heidelberg
- Ludwig Maximilian University of Munich
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD